Cytosolic Co-Delivery of miRNA-34a and Docetaxel With Core-Shell Nanocarriers via Caveolae-Mediated Pathway for the Treatment of Metastatic Breast Cancer

Scientific Reports - United Kingdom
doi 10.1038/srep46186
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Weekly Docetaxel in the Treatment of Metastatic Breast Cancer

Therapeutics and Clinical Risk Management
2008English

Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer

Frontiers in Pharmacology
Pharmacology
2019English

Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer—Challenges and Opportunities

Nanomaterials
Materials ScienceChemical Engineering
2018English

Co-Delivery of Curcumin and Paclitaxel by “Core-Shell” Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2019English

High Efficacy and Low Toxicity of Weekly Docetaxel Given as First-Line Treatment for Metastatic Breast Cancer

Oncology
MedicineCancer ResearchOncology
2005English

Core-Shell Nanocarriers With High Paclitaxel Loading for Passive and Active Targeting

Scientific Reports
Multidisciplinary
2016English

Vectors for Treatment of Metastatic Breast Cancer

2005English

Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
1999English

Synthesis of Magnetic Core-Branched Au Shell Nanostructures and Their Application in Cancer-Related miRNA Detection via SERS

Science China Materials
Materials Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy